Search

everythinglearnresearchcommunity

for

Search:↓

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

CBG may help with various medical conditions but needs more human research to confirm safety and effectiveness.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Adding a second method to PROTACs could improve cancer treatment.

BSSP may help skin tumors grow and could be a marker or target for skin cancer treatment.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Anti-androgens might help reduce COVID-19 severity in men.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

Bicalutamide may help treat female pattern hair loss.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Steroid 5α-reductase evolved from protists and diversified in eukaryotes, with specific roles in mammals and plants.

Resveratrol shows health benefits but faces challenges in effectiveness and regulation.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Balanced vitamin D levels are crucial to delay aging and prevent related diseases.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Testosterone pellet therapy may better address hormone imbalances in aging by focusing on local hormone production and symptom relief.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Hormones and genes affect hair growth and male baldness.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Higher PSA levels are linked to more hirsutism in women with PCOS.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

A group has developed therapies that show promise for treating cancer and various other conditions.